Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Return on Sales (2022 - 2026)

TriSalus Life Sciences has reported Return on Sales over the past 5 years, most recently at 0.0% for Q1 2026.

  • For Q1 2026, Return on Sales rose 1.0% year-over-year to 0.0%; the TTM value through Mar 2026 reached 0.01%, changed 0.0%, while the annual FY2025 figure was 0.01%, 0.0% changed from the prior year.
  • Return on Sales for Q1 2026 was 0.0% at TriSalus Life Sciences, up from 0.01% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.0% in Q1 2026 and troughed at 0.07% in Q4 2022.
  • A 5-year average of 0.02% and a median of 0.01% in 2025 define the central range for Return on Sales.
  • Biggest five-year swings in Return on Sales: grew 5bps in 2024 and later fell -1bps in 2025.
  • Year by year, Return on Sales stood at 0.07% in 2022, then grew by 11bps to 0.06% in 2023, then surged by 80bps to 0.01% in 2024, then soared by 40bps to 0.01% in 2025, then soared by 123bps to 0.0% in 2026.
  • Business Quant data shows Return on Sales for TLSI at 0.0% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.